Andrea Goldstein-Piekarski, PhD — Palo Alto, California

Andrea Goldstein-Piekarski, PhD is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Andrea Goldstein-Piekarski, PhD has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Alzheimer Disease, Mild Cognitive Impairment, Neuropsychiatric Symptoms.

Sponsors: Stanford University.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Palo Alto

Browse all research sites in California · View every site in Palo Alto

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Andrea Goldstein-Piekarski, PhD?

Andrea Goldstein-Piekarski, PhD has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Andrea Goldstein-Piekarski, PhD conducted?

Andrea Goldstein-Piekarski, PhD has 1 clinical trials on record, with 1 currently active. Their work covers Alzheimer Disease, Mild Cognitive Impairment, Neuropsychiatric Symptoms.

Is Andrea Goldstein-Piekarski, PhD accredited by Crixeo Clinical Trials?

Andrea Goldstein-Piekarski, PhD has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Andrea Goldstein-Piekarski, PhD?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.